Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (1y) (2021 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (1y) (2021 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 5.94% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -5.39% |
| Mar 31, 2024 | -99.94% |
| Dec 31, 2023 | -15.09% |
| Sep 30, 2023 | -99.81% |
| Jun 30, 2023 | -3.32% |
| Mar 31, 2023 | 0.40% |
| Dec 31, 2022 | 0.27% |
| Sep 30, 2022 | 3.17% |
| Jun 30, 2022 | -38.09% |
| Mar 31, 2022 | -0.50% |
| Dec 31, 2021 | -0.51% |
| Sep 30, 2021 | 0.34% |